Arix Bioscience plc
("Company")
PDMR notifications & Director Shareholdings
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The Company has been notified that Debra Barker, Non-Executive Director and Senior Independent Director purchased 26,000 Ordinary shares of 0.001 pence each in the Company ("Shares") on 03 May 2023 at a price of 106 pence per share.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Debra Barker | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Non-Executive Director | |||
| b)
| Initial notification /Amendment
| Initial Notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a)
| Name
| Arix Bioscience plc | |||
| b)
| LEI
| 213800OVT3AHQCXNIX43
| |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a)
| Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
| Identification code | GB00BD045071 | ||||
| b)
| Nature of the transaction
| Share purchase | |||
| c) | Price(s) and volume(s) | | Price(s) £ £1.06.00 | Volume(s) 26,000 | |
| d)
| Aggregated information | | |||
| - Aggregated volume | N/A (single transaction) | ||||
| - Price | £27,560.00 | ||||
| e)
| Date of the transaction
| 03 May 2023 | |||
| f)
| Place of the transaction
| London Stock Exchange | |||
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.